Magnetic Resonance Spectroscopy-Based Metabolomic Biomarkers for Typing, Staging, and Survival Estimation of Early-Stage Human Lung Cancer

Scientific Reports- United Kingdom

doi 10.1038/s41598-019-46643-5

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Serum and Plasma Metabolomic Biomarkers for Lung Cancer

Bioinformation
2017English

Diffusion-Weighted Magnetic Resonance Imaging May Identify Candidates for Alternatives to Lobectomy for Early Stage Lung Cancer

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

Investigation of Metabolomic Blood Biomarkers for Detection of Adenocarcinoma Lung Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2015English

P2.11-12 Metabolomic Analysis in Lung Cancer for Screening and Early Detection

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Utility of Magnetic Resonance in Preoperative Staging of Endometrial Cancer

Anales de la Facultad de Ciencias Médicas (Asunción)
2017English

Preoperative Staging of Colorectal Cancer — Computed Tomography and Magnetic Resonance Imaging

Scandinavian Journal of Surgery
Surgery
2003English

Immune Reprogramming via PD-1 Inhibition Enhances Early-Stage Lung Cancer Survival

JCI insight
Medicine
2018Luxembourgish

Social Factors, Treatment, and Survival in Early-Stage Non-Small Cell Lung Cancer.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy